Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5

Inflammatory Bowel Diseases

Volumn 14, Issue 12, 2008, Pages 1615-1622

  Weersma, Rinse K ^a   Zhou, Lu ^a   Nolte, Ilja M ^a   van der Steege, Gerrit ^a   van Dullemen, Hendrik M ^a   Oosterom, Elvira ^a   Bok, Lisette ^a   Peppelenbosch, Maikel P ^a   Faber, Klaas N ^a   Kleibeuker, John H ^a   Dijkstra, Gerard ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Crohn's disease; Genetics; Inflammatory bowel disease; Organic cation transporter; Runt related transcription factor 3; Solute carrier family 22; Transforming growth factor signaling; Ulcerative colitis

Indexed keywords

CARRIER PROTEIN; MESSENGER RNA; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 4; ORGANIC CATION TRANSPORTER 5; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; CASPASE RECRUITMENT DOMAIN PROTEIN 15; NOD2 PROTEIN, HUMAN; ORGANIC CATION TRANSPORTER; RUNX3 PROTEIN, HUMAN; SLC22A4 PROTEIN, HUMAN; SLC22A5 PROTEIN, HUMAN;

ADULT; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; EPISTASIS; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; ADOLESCENT; AGED; CASE CONTROL STUDY; CHILD; CHROMOSOME 5; COLON; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; GENETIC EPISTASIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHROMOSOMES, HUMAN, PAIR 5; COLITIS, ULCERATIVE; COLON; CORE BINDING FACTOR ALPHA 3 SUBUNIT; CROHN DISEASE; EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; ORGANIC CATION TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

EID: 59849093409     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20610     Document Type: Article

References (30)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347: 417-429.
2. Binder V, Both H, Hansen PK, et al. Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978. Gastroenterology. 1982;83:563-568.
3. Orholm M, Munkholm P, Langholz E, et al. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991;324:84-88.
4. Halfvarson J, Bodin L, Tysk C, et al. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology. 2003;124:1767-1773.
5. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature. 1996;379:821-823.
6. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434.
7. Rioux JD, Daly Mj, Silverberg MS, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet. 2001;29:223-228.
8. Peltekova VD, Wintle RF, Rubin LA, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet. 2004;36:471-475.
9. Torok HP, Glas J, Tonenchi L, et al. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut. 2005;54:1421-1427.
10. Brenner O, Levanon D, Negreanu V, et al. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc Natl Acad Sci U S A. 2004;101:16016-16021.
11. Li QL, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 2002;109:113-124.
12. Balmain A. Cancer: new-age tumour suppressors. Nature. 2002;417: 235-237.
13. Alarcon-Riquelme ME. Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus. Arthritis Res Ther. 2004;6: 169-173.
14. Levanon D, Negreanu V, Bernstein Y, et al. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics. 1994;23:425-432.
15. Cho JH, Nicolae DL, Gold LH, et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A. 1998;95:7502-7507.
16. Harrell LE, Baechler EC, Behrens TW, et al. MDR1, RUNX3 and TGF-βRii pathways implicated in human IBD. Gastroenterology DDW Abstract; 2006:A591.
17. Tokuhiro S, Yamada R, Chang X, et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet. 2003;35:341-348.
18. Weersma RK, Zhernakova A, Nolte IM, et al. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands. Am J Gastroenterol. 2008;103:621-627.
19. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the Inflammatory Bowel Diseases World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2005;11:567-575.
20. Blokzijl H, Vander Borght S, Bok LI, et al. Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels. Inflamm Bowel Dis. 2007;13:710-720.
21. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000;132:365-386.
22. Oostenbrug LE, Nolte IM, Oosterom E, et al. CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis. Dig Liver Dis. 2006;38:834-845.
23. de Jong MM, Nolte IM, de Vries EG, et al. The HLA class III subregion is responsible for an increased breast cancer risk. Hum Mol Genet. 2003;12:2311-2319.
24. Kulkarni AB, Huh CG, Becker D, et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993;90:770-774.
25. Gorelik L, Flavell RA. Transforming growth factor-beta in T-cell biology. Nat Rev Immunol. 2002;2:46-53.
26. Surinya KH, Cox TC, May BK. Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene. J Biol Chem. 1998;273:16798-16809.
27. Ghayor C, Herrouin JF, Chadjichristos C, et al. Regulation of human COL2A1 gene expression in chondrocytes. Identification of C-Krox-responsive elements and modulation by phenotype alteration. J Biol Chem. 2000;275:27421-27438.
28. Ito K, Liu Q, Salto-Tellez M, et al. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res. 2005;65:7743-7750.
29. Silverberg MS, Duerr RH, Brant SR, et al. Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. Eur J Hum Genet. 2007;15:328-335.
30. Guo C, Ding J, Yao L, et al. Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1. Int J Cancer. 2005;116:155-160.